secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rapport Therapeutics, Inc. (RAPP)
CIK:        0002012593
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158327
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapport Therapeutics closes private placement of 1,058,824 shares at $17.00 per share with existing stockholders
--------------------------------------------------------------------------------

- Entered Stock Purchase Agreements with Sofinnova Venture Partners and affiliates of Goldman Sachs for 1,058,824 shares at $17.00/share, concurrent with IPO.
- Private placement closed June 10, 2024; placement agents included Goldman Sachs, Jefferies, TD Securities, and Stifel.
- Shares issued under Section 4(a)(2) exemption to institutional accredited investors; Sofinnova granted registration rights after one-year anniversary.
- Filed third amended and restated certificate of incorporation and bylaws in connection with IPO effectiveness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/0001193125-24-158327-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/d60139d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158327

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer